Latest Breaking News On - பார்மா குழு - Page 10 : comparemela.com

Vifor Pharma and Travere Therapeutics announce licensing agreement for the commercialization of sparsentan in Europe, Australia and New Zealand

Press release content from Business Wire. The AP news staff was not involved in its creation.

Vifor Pharma Group: Vifor Pharma and Travere Therapeutics announce licensing agreement for the commercialization of sparsentan in Europe, Australia and New Zealand

Sparsentan is a potential first-in-class treatment to address significant unmet medical need in rare kidney disorders focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)

Acacia Pharma Announces Initiation of Pivotal Study of

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014. Cambridge, UK and.

+++ Corona-News aktuell +++: 3000 Gesundheitskräfte wegen Impfpflicht in Frankreich suspendiert

Darum braucht es eine Auffrischungsimpfung von Biontech